Status:
COMPLETED
Compound Herbal Formula (TPE-1) for Leukopenia and Cancer-related Fatigue in Breast Cancer Patients With Radiotherapy
Lead Sponsor:
Taipei City Hospital
Collaborating Sponsors:
Taipei Medical University Shuang Ho Hospital
Conditions:
Breast Cancer
Radiotherapy
Eligibility:
FEMALE
18-70 years
Phase:
PHASE2
PHASE3
Brief Summary
Many breast cancer patients will taking Chinese herbal medicine during receiving radiotherapy. The investigators conducted the pilot study showing Compound Herbal Formula (TPE-1) have the effect of im...
Detailed Description
TPE-1 is designed according to TCM concept. It is not anti-cancer directly, it is enhancing the Qi flow and immunity of breast cancer when they are just finishing chemotherapy and on going radiotherap...
Eligibility Criteria
Inclusion
- breast cancer
- age between 18 to 70 yrs
- finished chemotherapy (adriamycin ), will receiving radiotherapy
- Chinese population
- KP$ between 40-100
- ECOG \< 2
- WBC \>4X10(9)／L and Hb \> 10g/dl
- Assigned informed concent.
Exclusion
- receiving operation during 14 days
- blood transfusion during one month.
- ALT \>100mg/dL
- Creatinine \>2.0mg/dL
- Total bilirubin \>2.0mg/dL
- Infection
- prolation
- Taking anti-seizure , psychological drugs or any drugs not suitable patients
- AIDS or any disease diagnosed by physician and not suitable patients.
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01142479
Start Date
May 1 2010
Last Update
May 29 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shuang Ho Hospital
Taipei, Taiwan, Taiwan, 886